Fig. 5: Sensitivities by stage for simultaneous detection of three cancer types using EV protein biomarkers. | Communications Medicine

Fig. 5: Sensitivities by stage for simultaneous detection of three cancer types using EV protein biomarkers.

From: Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test

Fig. 5

a Sensitivity for detecting either stage I (N = 22) or stage II (N = 25) pancreatic cancer. b Sensitivity for detecting either stage I (N = 39) or stage II (N = 5) ovarian cancer. c Sensitivity for detecting either stage I (N = 27) or stage II (N = 21) bladder cancer. All sensitivities represent values at >99% specificity for the held-out test sets. Error bars in all panels represent the two-sided 95% Wilson confidence intervals.

Back to article page